Ultrastructure of a human chorionic gonadotropin-and adrenocorticotropin-responsive functioning Sertoli-Leydig cell tumor (type I)
Kalderon, A.E.; Tucci, J.R.
Laboratory Investigation; a Journal of Technical Methods and Pathology 29(1): 81-89
1973
ISSN/ISBN: 0023-6837 PMID: 4353887 Document Number: 62806
Document emailed within 1 workday
Related Documents
Zaydon, C.; Bogaars, H.A.; Tucci, J.R. 1989: Virilizing granulosa cell tumor responsive to human chorionic gonadotropin and oral contraceptive with 8-year followup International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 29(1): 87-90Larsen, W.G.; Felmar, E.A.; Wallace, M.E.; Frieder, R. 1992: Sertoli-Leydig cell tumor of the ovary: a rare cause of amenorrhea Obstetrics and Gynecology 79(5): 831-833
Mathur, S.R.; Bhatla, N.; Rao, I.Satish.; Singh, M.K. 2003: Sertoli Leydig cell tumor with heterologous gastrointestinal epithelium: a case report Indian Journal of Pathology and Microbiology 46(1): 91-93
Yamauchi, M.; Yoshigoe, F.; Mera, F.; Ogura, K.; Kameda, H.; Nakada, J.; Takasaka, S.; Machida, T.; Fukunaga, M. 1983: An autopsy case of double cancer (Hepatocellular carcinoma and mixed germ cell tumor of the testis)--significance of alpha-fetoprotein and human chorionic gonadotropin as tumor markers Gan no Rinsho. Japan Journal of Cancer Clinics 29(4): a
Carnio, E.C.; Varanda, W.A. 1995: Calcium-activated potassium channels are involved in the response of mouse Leydig cells to human chorionic gonadotropin Brazilian Journal of Medical and Biological Research 28(7): 813-824
Roth, L.M.; Cleary, R.E.; Rosenfield, R.L. 1974: Sertoli-Leydig cell tumor of the ovary, with an associated mucinous cystadenoma. An ultrastructural and endocrine study Laboratory Investigation; a Journal of Technical Methods and Pathology 31(6): 648-657
Ueda, G.; Yamasaki, M.; Sato, Y.; Hiramatsu, K.; Matsumoto, K. 1976: Light and electron microscopic study of an intermediate sertoli-leydig cell tumor with a review of literatures in Japan Acta Obstetrica et Gynaecologica Japonica 23(1): 14-22
Vaitukaitis, J.L. 1974: Human chorionic gonadotropin as a tumor marker Annals of Clinical and Laboratory Science 4(4): 276-280
Huneeus, A.; Alba, F.; Fernández, W.; Valladares, L. 1999: Sertoli-Leydig tumor. Clinical case Revista Medica de Chile 127(7): 835-838
Gilcrease, M.Z.; Delgado, R.; Albores-Saavedra, J. 1998: Testicular Sertoli cell tumor with a heterologous sarcomatous component: immunohistochemical assessment of Sertoli cell differentiation Archives of Pathology and Laboratory Medicine 122(10): 907-911
Zamurovic, M.; Soldo, V.; Cutura, N. 2013: Bilateral poorly differentiated Sertoli-Leydig ovarian tumor associated with dysgerminoma: case report European Journal of Gynaecological Oncology 34(6): 575-576
Clinton, C.W.; Rogaly, E.; Bernstein, J. 1981: Leydig-Sertoli cell tumour in the postmenopausal female. A case report South African Medical Journal 60(11): 434-435
Mano, H.; Hattori, S.; Furuhashi, Y.; Goto, S.; Tomoda, Y.; Naoi, M. 1984: Specific in vitro effects of methotrexate entrapped into liposomes bearing antibody fragments against human chorionic gonadotropin on cell growth of cultured human choriocarcinoma cells Gan to Kagaku Ryoho. Cancer and ChemoTherapy 11(9): 1775-1780
Livni, N.; Palti, Z.; Segal, S.; Laufer, A. 1977: Fine structure of Sertoli and Leydig cells in azoospermic human testis Archives of Pathology and Laboratory Medicine 101(8): 442-445
Teodorczyk-Injeyan, J.A.; Kellen, J.A. 1988: Chorionic gonadotropin-induced cell proliferation and polyclonal immunoglobulin synthesis in human mononuclear cells Biomedicine and PharmacoTherapy 42(1): 49-53
Garcia, J.; Kholkute, S.D.; Dukelow, W.R. 1993: The efficacy of stored pregnant mares' serum gonadotropin and human chorionic gonadotropin on inducing ovulation in mice Laboratory Animal Science 43(2): 198-199
Boitani, C.; Chen, C.L.; Margioris, A.N.; Gerendai, I.; Morris, P.L.; Bardin, C.W. 1986: Pro-opiomelanocortin-derived peptides in the testis: evidence for a possible role in Leydig and Sertoli cell function Medical Biology 63(5-6): 251-258
Latthe, P.; Shafi, M.I.; Rollason, T.P. 2000: Recurrence of Sertoli-Leydig cell tumour in contralateral ovary. Case report and review of literature European Journal of Gynaecological Oncology 21(1): 62-63
Dubourdieu, S.; Charbonnel, B.; Massai, M.R.; Marraoui, J.; Spitz, I.; Bouchard, P. 1991: Suppression of corpus luteum function by the gonadotropin-releasing hormone antagonist Nal-Glu: effect of the dose and timing of human chorionic gonadotropin administration Fertility and Sterility 56(3): 440-445
Kim, C.-H.; Ahn, J.-W.; You, R.-M.; Kim, S.-H.; Chae, H.-D.; Kang, B.-M. 2014: Combined administration of gonadotropin-releasing hormone agonist with human chorionic gonadotropin for final oocyte maturation in GnRH antagonist cycles for in vitro fertilization Journal of Reproductive Medicine 59(1-2): 63-68